MediPharm Labs Corp.
MEDIF
$0.0554
-$0.0046-7.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.72M | -269.70K | -1.23M | -2.03M | -1.89M |
| Total Depreciation and Amortization | 302.80K | 296.10K | 400.80K | 379.80K | 534.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 224.10K | 241.80K | -516.50K | 525.00K | 600.00K |
| Change in Net Operating Assets | 196.60K | -2.37M | 586.50K | 643.70K | -420.20K |
| Cash from Operations | -2.00M | -2.10M | -762.20K | -485.40K | -1.17M |
| Capital Expenditure | -30.40K | -29.30K | -31.40K | -24.20K | -40.90K |
| Sale of Property, Plant, and Equipment | 3.07M | -- | 0.00 | -- | 15.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.04M | -29.30K | -31.40K | -24.20K | -25.60K |
| Total Debt Issued | 500.00K | -- | 0.00 | 50.00K | 749.00K |
| Total Debt Repaid | -84.00K | -265.00K | -337.00K | -2.29M | -153.00K |
| Issuance of Common Stock | -- | -- | 14.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 31.00K | 56.00K | 79.00K | 20.00K | 89.00K |
| Cash from Financing | 323.10K | -145.60K | -174.30K | -1.63M | 500.60K |
| Foreign Exchange rate Adjustments | 27.50K | 11.10K | -33.60K | 13.20K | 15.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.39M | -2.26M | -1.00M | -2.13M | -683.30K |